Kumar, B.; Ahmad, R.; Sharma, S.; Gowrikumar, S.; Primeaux, M.; Rana, S.; Natarajan, A.; Oupicky, D.; Hopkins, C.R.; Dhawan, P.;
et al. PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells. Cancers 2021, 13, 2168.
https://doi.org/10.3390/cancers13092168
AMA Style
Kumar B, Ahmad R, Sharma S, Gowrikumar S, Primeaux M, Rana S, Natarajan A, Oupicky D, Hopkins CR, Dhawan P,
et al. PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells. Cancers. 2021; 13(9):2168.
https://doi.org/10.3390/cancers13092168
Chicago/Turabian Style
Kumar, Balawant, Rizwan Ahmad, Swagat Sharma, Saiprasad Gowrikumar, Mark Primeaux, Sandeep Rana, Amarnath Natarajan, David Oupicky, Corey R. Hopkins, Punita Dhawan,
and et al. 2021. "PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells" Cancers 13, no. 9: 2168.
https://doi.org/10.3390/cancers13092168
APA Style
Kumar, B., Ahmad, R., Sharma, S., Gowrikumar, S., Primeaux, M., Rana, S., Natarajan, A., Oupicky, D., Hopkins, C. R., Dhawan, P., & Singh, A. B.
(2021). PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells. Cancers, 13(9), 2168.
https://doi.org/10.3390/cancers13092168